NCT00000344已完成2 期
Trial of Buprenorphine/Naloxone for Treatment of Opiate Dependence
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 40
- 试验地点
- 2
研究概览
简要总结
The purpose of this study is to determine the efficacy and safety of a buprenorphine/naloxone sublingual tablet formulation as an office-based therapy for opiate-dependence treatment.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 21 Years 至 50 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •M/F ages 21-
- •Meet DSM-IV criteria for opiate dependence. Agree to conditions of the study and sign informed consent.
排除标准
- •Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and/or nuring women. Dependence on ETOH or benzodiazepines or other sedative/hypnotics. Acute hepatitis. Other medical condtions that deem participation to be unsafe.
研究者
研究点 (2)
Loading locations...
相似试验
已完成
2 期
Trial of Buprenorphine/Naloxone for Opiate Dependence - 2Opioid-Related DisordersSubstance-Related DisordersNCT00000353National Institute on Drug Abuse (NIDA)
撤回
2 期
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1 - 1Heroin DependenceOpioid-Related DisordersNCT00000326University of Colorado, Denver
已完成
2 期
Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1Opioid-Related DisordersSubstance-Related DisordersNCT00015028National Institute on Drug Abuse (NIDA)
已完成
4 期
Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14Opioid DependenceSubstance-Related DisordersNCT00015340National Institute on Drug Abuse (NIDA)582
撤回
2 期
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment III) - 3Heroin DependenceOpioid-Related DisordersNCT00000328University of Colorado, Denver